Figure 4 | Scientific Reports

Figure 4

From: Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis

Figure 4

Treatment effects on NAFLD Activity Score and fibrosis stage. (A) Change in mean non-alcoholic fatty liver disease activity score (NAS). Significance is vs. ALT-801 10 nmol/kg. (B) Change in individual NAS. (C) Change in mean fibrosis stage. (D) Change in individual fibrosis stages. The points at each scoring step are slightly shifted to allow visual separation of the animals. This presentation is only for visualization purposes and does not reflect any difference in score. ****p < 0.0001.

Back to article page